MeiraGTx Holdings (MGTX) Capital Leases (2017 - 2025)
MeiraGTx Holdings' (MGTX) quarterly Capital Leases came in at $109000.0 in Q4 2025, down 99.36% on a QoQ basis from $17.1 million in Q3 2020.
MeiraGTx Holdings (MGTX) Capital Leases (2017 - 2025) Analysis & Trends
MeiraGTx Holdings (MGTX) has 5 years of Capital Leases data on file, last reported at $109000.0 in Q4 2025.
- Quarterly Capital Leases changed N/A year-over-year to $109000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $109000.0 (changed N/A YoY) and the FY2025 annual result came in at $109000.0, changed N/A from the prior year.
- Capital Leases eased to $109000.0 in Q4 2025, from $17.1 million in the prior quarter.
- In the past five years, Capital Leases ranged from a high of $109000.0 in Q4 2025 to a low of $109000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | MeiraGTx Holdings | 1.10 Bn | 1.03 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 109,000.00 |
| Sep 30, 2020 | 17.13 Mn |
| Jun 30, 2020 | 18.56 Mn |
| Mar 31, 2020 | 19.17 Mn |
| Dec 31, 2019 | 21.50 Mn |
| Sep 30, 2019 | 20.60 Mn |
| Jun 30, 2019 | 15.39 Mn |
| Mar 31, 2019 | 2.91 Mn |
| Dec 31, 2018 | 7,097.00 |
| Sep 30, 2018 | 12,092.00 |
| Jun 30, 2018 | 20,732.00 |
| Dec 31, 2017 | 34,298.00 |